Isovue-300 61% Inj, 50ml

Manufacturer BRACCO DIAGNOSTICS Active Ingredient Iopamidol(eye oh PA mi dole) Pronunciation eye-oh-PA-mi-dole
WARNING: Some products must not be given into the spine. Very bad and sometimes deadly health problems have happened when these products were given into the spine. This includes coma, heart attack, kidney failure, paralysis, seizures, high body temperature, a muscle problem called rhabdomyolysis, or brain problems like bleeding or swelling. Talk with the doctor. @ COMMON USES: It is used before a CT scan or other test.
đŸˇī¸
Drug Class
Diagnostic Agents
đŸ§Ŧ
Pharmacologic Class
Non-ionic, Iodinated Contrast Media
🤰
Pregnancy Category
B
✅
FDA Approved
Aug 1985
âš–ī¸
DEA Schedule
Not Controlled

Overview

â„šī¸

What is this medicine?

Iopamidol is a special dye, called a contrast agent, that is injected into your body, usually into a vein. It helps doctors see your blood vessels, organs, or other body parts more clearly on X-ray images, like CT scans or angiograms. It makes certain areas 'light up' so problems can be identified.
📋

How to Use This Medicine

Taking Your Medication Correctly

To ensure safe and effective use of this medication, follow your doctor's instructions carefully. Read all the information provided to you and adhere to the guidelines.

Before receiving this medication, it is essential to be well-hydrated. Your doctor may advise you to drink extra fluids before administration to prevent dehydration. After receiving the medication, drink plenty of non-caffeinated liquids, unless your doctor instructs you to limit your fluid intake.

In some cases, your doctor may prescribe other medications to be taken before this drug to minimize potential side effects.

Storage and Disposal

This medication will be administered to you in a healthcare setting, and you will not need to store it at home.

Missed Dose

As this medication is given in a healthcare setting, you will not need to worry about missing a dose. Your healthcare provider will administer the medication as scheduled.
💡

Lifestyle & Tips

  • Stay well-hydrated before and after the procedure, especially if you have kidney problems or diabetes, to help your kidneys clear the dye.
  • Inform your doctor about all your medical conditions, allergies (especially to iodine or previous contrast reactions), and all medications you are taking, particularly for diabetes (like Metformin) or kidney disease.
  • Follow all instructions given by your healthcare provider regarding fasting or medication adjustments before the procedure.
💊

Available Forms & Alternatives

Dosing & Administration

đŸ‘¨â€âš•ī¸

Adult Dosing

Standard Dose: Highly variable based on procedure and patient weight. For Isovue-300 (300 mgI/mL):

Condition-Specific Dosing:

Cerebral Angiography: 5-10 mL per injection, total up to 100 mL
Peripheral Angiography: 5-75 mL per injection, total up to 250 mL
Coronary Angiography: 3-10 mL per injection, total up to 250 mL
CT Head: 50-150 mL (single bolus or infusion)
CT Body: 50-150 mL (single bolus or infusion)
Urography: 50-100 mL (bolus or infusion)
đŸ‘ļ

Pediatric Dosing

Neonatal: Not established for all procedures; use with extreme caution and reduced doses. Typically 1-3 mL/kg, max 50 mL.
Infant: 1-3 mL/kg, max 50-100 mL depending on procedure and concentration.
Child: 1-3 mL/kg, max 50-100 mL depending on procedure and concentration.
Adolescent: Dosing approaches adult recommendations, typically 1-3 mL/kg, max 100-150 mL.
âš•ī¸

Dose Adjustments

Renal Impairment:

Mild: No specific dose adjustment, but ensure adequate hydration.
Moderate: Increased risk of contrast-induced nephropathy (CIN). Hydration is critical. Consider lower dose or alternative imaging. Monitor renal function post-procedure.
Severe: High risk of CIN. Avoid if possible. If essential, use lowest effective dose, ensure aggressive hydration, and consider dialysis post-procedure if patient is on dialysis. Close monitoring of renal function.
Dialysis: Can be used in patients on dialysis, as it is dialyzable. Timing of dialysis post-contrast administration may be considered to remove contrast, but not strictly necessary to prevent CIN in patients already on dialysis.

Hepatic Impairment:

Mild: No specific dose adjustment.
Moderate: No specific dose adjustment.
Severe: No specific dose adjustment, as primarily renally excreted. However, general caution in severely ill patients.

Pharmacology

đŸ”Ŧ

Mechanism of Action

Iopamidol is a non-ionic, water-soluble, tri-iodinated benzoic acid derivative. When injected intravascularly, it increases the attenuation of X-rays in the areas of the body where it distributes. The iodine atoms in the molecule absorb X-rays, creating a contrast between the opacified structures (e.g., blood vessels, urinary tract) and surrounding tissues, allowing for visualization on radiographic images.
📊

Pharmacokinetics

Absorption:

Bioavailability: 100%
Tmax: Immediate (after IV bolus)
FoodEffect: Not applicable (IV administration)

Distribution:

Vd: Approximately 0.16 L/kg (similar to extracellular fluid volume)
ProteinBinding: < 2%
CnssPenetration: Limited (does not cross intact blood-brain barrier)

Elimination:

HalfLife: Approximately 2 hours
Clearance: Renal clearance is approximately 100 mL/min (similar to GFR)
ExcretionRoute: Primarily renal (glomerular filtration)
Unchanged: > 90% within 24 hours
âąī¸

Pharmacodynamics

OnsetOfAction: Immediate (upon injection)
PeakEffect: Immediate (upon injection and circulation to target area)
DurationOfAction: Minutes to hours, depending on blood flow, renal function, and specific procedure (e.g., vascular opacification lasts minutes, urinary tract opacification lasts hours).

Safety & Warnings

âš ī¸

Side Effects

Urgent Side Effects: Seek Medical Help Right Away

Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek medical attention immediately:

Allergic reactions: Rash, hives, itching, redness, swelling, blistering, or peeling skin (with or without fever), wheezing, tightness in the chest or throat, difficulty breathing, swallowing, or speaking, unusual hoarseness, or swelling of the mouth, face, lips, tongue, or throat. In rare cases, allergic reactions can be fatal.
Kidney problems: Inability to urinate, changes in urine output, blood in the urine, or significant weight gain.
Thyroid problems: Weight changes, nervousness, excitability, restlessness, weakness, hair thinning, depression, eye or neck swelling, difficulty focusing, heat or cold intolerance, menstrual changes, shakiness, or sweating.
Cardiovascular issues: Chest pain or pressure, rapid or irregular heartbeat.
Severe dizziness or fainting: Sudden loss of balance or consciousness.
Respiratory problems: Shortness of breath.
Blood clots or circulatory issues: Swelling, warmth, numbness, color changes, or pain in a leg or arm.
Neurological problems: Weakness on one side of the body, difficulty speaking or thinking, balance changes, facial drooping, or blurred vision.
Severe skin reactions: Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), or other serious reactions, which can occur anywhere from 1 hour to several weeks after receiving the medication. These reactions can affect body organs and be life-threatening. Seek medical help immediately if you experience red, swollen, blistered, or peeling skin; red or irritated eyes; sores in your mouth, throat, nose, eyes, genitals, or skin; fever; chills; body aches; shortness of breath; or swollen glands.

Additional Side Effects (Injection into the Spine)

If you receive this medication via spinal injection, you may also experience:

Seizures
Back pain
Stiff neck
Abnormal burning, numbness, or tingling sensations

Other Side Effects

Most people do not experience significant side effects, but some may occur. If you notice any of the following side effects or any other unusual symptoms, contact your doctor or seek medical attention:

Injection (into the spine): Headache, upset stomach, vomiting, muscle pain
* All other injection products: Feeling of warmth, hot flashes, upset stomach

Reporting Side Effects

This is not an exhaustive list of potential side effects. If you have questions or concerns, contact your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
🚨

Seek Immediate Medical Attention If You Experience:

  • Any rash, itching, or hives after the injection.
  • Swelling of your face, lips, tongue, or throat.
  • Difficulty breathing, wheezing, or tightness in your chest.
  • Feeling dizzy, lightheaded, or faint.
  • Nausea or vomiting.
  • Pain, swelling, or redness at the injection site.
  • Any new or worsening symptoms after the procedure, especially decreased urination or swelling in your legs/feet.
📋

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about the following conditions and situations to ensure safe treatment:

Any allergies you have, including allergies to this medication, its components, or other substances. Be sure to describe the allergic reaction you experienced, including any symptoms that occurred.
If you are dehydrated, have been experiencing poor nutrition, or have recently used a laxative or diuretic (water pill).
If you have a medical condition called homocystinuria.
If you have had a skin reaction to this medication or a similar medication in the past.
If you are currently taking metformin.

Additional Considerations for Injection Administration (Intrathecal):

If you have an active infection.
* If you are taking any medications that may increase the risk of seizures or have taken such a medication within the last 48 hours. There are numerous medications that can increase seizure risk, so it is crucial to consult with your doctor or pharmacist if you are unsure.

This list is not exhaustive, and it is vital to discuss all your medications (prescription, over-the-counter, natural products, and vitamins) and health conditions with your doctor and pharmacist. They will help you determine if it is safe to take this medication with your other medications and health conditions. Never start, stop, or adjust the dosage of any medication without first consulting your doctor.
âš ī¸

Precautions & Cautions

Important Warnings and Cautions for Patients Taking This Medication

It is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication. This is crucial because combining this drug with certain procedures can increase the risk of blood clots, which may lead to heart attack and stroke, potentially resulting in fatal outcomes. If you have any questions or concerns, discuss them with your doctor.

Be aware that this medication can cause tissue damage if it leaks from the vein during administration. Monitor the injection site closely and immediately report any signs of redness, burning, pain, swelling, blisters, skin sores, or fluid leakage to your nurse.

Regular blood tests may be necessary to monitor your condition. Consult with your doctor to determine the frequency of these tests.

This medication may interfere with certain laboratory tests, so it is vital to inform all your healthcare providers and laboratory personnel that you are taking this drug.

If you are 65 years or older, use this medication with caution, as you may be more susceptible to side effects.

Pregnant or breastfeeding women, or those planning to become pregnant, should discuss the potential benefits and risks of this medication with their doctor.

Special Considerations for Children

When administering this medication to children, exercise caution, as the risk of side effects may be higher in certain pediatric populations. In children under 3 years of age, the use of similar medications has been associated with low thyroid function, which can impact child development. Your child's doctor may recommend regular thyroid function tests after the injection to monitor for potential effects. If you have any questions or concerns, consult with your child's doctor.
🆘

Overdose Information

Overdose Symptoms:

  • Severe hypotension (low blood pressure)
  • Bradycardia (slow heart rate)
  • Tachycardia (fast heart rate)
  • Cardiac arrest
  • Respiratory distress
  • Seizures
  • Acute renal failure

What to Do:

Overdose is rare due to rapid excretion. Treatment is supportive and symptomatic. Maintain airway, breathing, and circulation. Monitor vital signs. Iopamidol is dialyzable, so hemodialysis can be used to remove it from the body if necessary, especially in patients with severe renal impairment or overdose. Call 1-800-222-1222 (Poison Control) or seek immediate medical attention.

Drug Interactions

🔴

Major Interactions

  • Metformin (in patients with acute kidney injury or severe chronic kidney disease): Increased risk of lactic acidosis. Metformin should be withheld at the time of or prior to the procedure and for 48 hours after, and reinstituted only after renal function is stable.
  • Interleukin-2 (IL-2): Increased risk of delayed, severe, or prolonged adverse reactions (e.g., fever, rash, flu-like symptoms, renal dysfunction).
🟡

Moderate Interactions

  • Beta-blockers: May blunt the compensatory cardiovascular responses to anaphylaxis, making treatment of severe hypersensitivity reactions more difficult.
  • Diuretics: May increase the risk of contrast-induced nephropathy, especially in dehydrated patients.
  • Nephrotoxic drugs (e.g., NSAIDs, aminoglycosides): Concomitant use may increase the risk of contrast-induced nephropathy.

Monitoring

đŸ”Ŧ

Baseline Monitoring

Renal function (Serum Creatinine, eGFR)

Rationale: To assess baseline kidney function and risk of contrast-induced nephropathy (CIN).

Timing: Prior to contrast administration, especially in at-risk patients.

Allergy history (especially to contrast media, iodine, or shellfish)

Rationale: To identify patients at increased risk of hypersensitivity reactions.

Timing: Prior to contrast administration.

Medication history (especially Metformin, beta-blockers, nephrotoxic drugs)

Rationale: To identify potential drug interactions and adjust medication regimen if necessary.

Timing: Prior to contrast administration.

Hydration status

Rationale: Dehydration increases CIN risk. Ensure adequate hydration.

Timing: Prior to contrast administration.

📊

Routine Monitoring

Vital Signs (BP, HR, RR, O2 Sat)

Frequency: Before, during, and immediately after injection, then as clinically indicated.

Target: Within patient's normal limits.

Action Threshold: Significant deviations (e.g., hypotension, tachycardia, bradycardia, desaturation) require immediate assessment and intervention.

Signs/Symptoms of Hypersensitivity Reaction

Frequency: Continuously during and for at least 30 minutes post-injection (delayed reactions can occur hours later).

Target: Absence of symptoms.

Action Threshold: Rash, urticaria, pruritus, angioedema, bronchospasm, laryngeal edema, hypotension, shock.

Injection Site Assessment

Frequency: During and immediately after injection.

Target: Absence of pain, swelling, redness.

Action Threshold: Pain, swelling, extravasation, signs of phlebitis.

Renal Function (Serum Creatinine, eGFR)

Frequency: 24-72 hours post-procedure in high-risk patients (e.g., pre-existing CKD, diabetes, dehydration, concomitant nephrotoxic drugs).

Target: Within baseline limits.

Action Threshold: Increase in serum creatinine by â‰Ĩ 0.3 mg/dL or â‰Ĩ 50% from baseline within 48-72 hours.

đŸ‘ī¸

Symptom Monitoring

  • Rash
  • Hives (urticaria)
  • Itching (pruritus)
  • Swelling of face, lips, tongue, or throat (angioedema)
  • Difficulty breathing (dyspnea, bronchospasm)
  • Wheezing
  • Cough
  • Dizziness or lightheadedness
  • Nausea
  • Vomiting
  • Headache
  • Flushing
  • Injection site pain or swelling
  • Chest pain
  • Palpitations
  • Signs of kidney injury (decreased urine output, swelling)

Special Patient Groups

🤰

Pregnancy

Iopamidol is Pregnancy Category B. Animal reproduction studies have shown no evidence of fetal harm. However, there are no adequate and well-controlled studies in pregnant women. It should be used during pregnancy only if clearly needed and the potential benefit justifies the potential risk to the fetus. Fetal thyroid function should be monitored if exposure occurs.

Trimester-Specific Risks:

First Trimester: No known specific increased risk, but organogenesis occurs. Use only if essential.
Second Trimester: No known specific increased risk. Fetal thyroid may be more susceptible to iodine effects.
Third Trimester: No known specific increased risk. Fetal thyroid may be more susceptible to iodine effects. Transient hypothyroidism in the neonate has been reported with other iodinated contrast agents.
🤱

Lactation

Iopamidol is excreted into breast milk in small amounts. Due to poor oral absorption by the infant, systemic exposure is minimal. The American College of Radiology (ACR) and European Society of Urogenital Radiology (ESUR) generally consider iodinated contrast agents compatible with breastfeeding. A common recommendation is to consider temporarily interrupting breastfeeding for 12-24 hours after contrast administration, though this is often not strictly necessary.

Infant Risk: Low risk. Minimal systemic absorption by the infant. Potential for transient diarrhea or allergic reaction is theoretical but rare.
đŸ‘ļ

Pediatric Use

Dosing is weight-based and procedure-dependent. Pediatric patients, especially neonates and infants, may be more susceptible to fluid shifts and adverse reactions. Careful attention to hydration status, dose calculation, and monitoring is crucial. Renal function should be assessed.

👴

Geriatric Use

Elderly patients are at increased risk for contrast-induced nephropathy due to age-related decline in renal function, comorbidities (e.g., diabetes, hypertension), and polypharmacy. Careful assessment of renal function, hydration, and potential drug interactions is essential. Use the lowest effective dose and ensure adequate hydration.

Clinical Information

💎

Clinical Pearls

  • Always assess patient's renal function (Cr, eGFR) and allergy history prior to contrast administration.
  • Ensure adequate hydration before and after the procedure, especially in patients at risk for contrast-induced nephropathy (CIN).
  • For patients on Metformin, follow institutional guidelines for withholding and restarting the medication to prevent lactic acidosis. Typically, withhold at time of or prior to procedure and for 48 hours after, restarting only after renal function is stable.
  • Be prepared for hypersensitivity reactions, ranging from mild (urticaria) to severe (anaphylaxis). Have emergency equipment and medications readily available.
  • Extravasation can occur; monitor injection site closely. Manage with cold compresses and elevation.
  • Non-ionic contrast agents like Iopamidol generally have a lower incidence of adverse reactions compared to older ionic agents.
  • Consider premedication with corticosteroids and antihistamines for patients with a history of previous contrast reactions or significant allergies, as per institutional protocols.
🔄

Alternative Therapies

  • Other iodinated contrast media (e.g., Iohexol, Ioversol, Iodixanol, Iopromide)
  • Gadolinium-based contrast agents (for MRI, different mechanism)
  • Ultrasound (non-ionizing, no contrast or microbubble contrast)
  • Non-contrast CT or MRI (when sufficient for diagnosis)
💰

Cost & Coverage

Average Cost: Varies widely by concentration, volume, and supplier. Typically ranges from $50 - $200+ per 50mL vial. per 50mL vial
Generic Available: Yes
Insurance Coverage: Generally covered by medical insurance for diagnostic imaging procedures when medically necessary.
📚

General Drug Facts

If your symptoms or health problems persist or worsen, it is essential to contact your doctor for further guidance. To ensure safe use, never share your medication with others, and do not take medication prescribed for someone else. Store all medications in a secure location, out of reach of children and pets, to prevent accidental ingestion. Dispose of unused or expired medications properly; do not flush them down the toilet or pour them down the drain unless instructed to do so by a healthcare professional. If you are unsure about the correct disposal method, consult your pharmacist, who can also inform you about potential drug take-back programs in your area. Additionally, some medications may come with a separate patient information leaflet, which your pharmacist can provide. If you have any questions or concerns about your medication, discuss them with your doctor, nurse, pharmacist, or other healthcare provider. In the event of a suspected overdose, immediately contact your local poison control center or seek medical attention. Be prepared to provide information about the medication taken, the amount, and the time it occurred to ensure prompt and effective treatment.